Company: PFSA
Filing Date: 2025-05-13
Form Type: S-4/A
Source: 0001213900-25-042224
Chunk: 486

Company: Profusa, Inc.
Filing Date: 2025-05-13
Form: S-4/A
Chunk 486
---
 2025 |        |     | Thereafter |   |
|:------------------------------|:----|:------|-------:|:----|:-----|-------:|:----|:-----------|:--|
| Convertible notes             |     | $     | 18,419 |     | $    | 18,419 |     | $          | — |
| Tasly Convertible Loan        |     |       |  2,234 |     |      |  2,234 |     |            | — |
| Senior notes                  |     |       | 25,268 |     |      | 25,268 |     |            | — |
| Promissory Notes              |     |       |    910 |     |      |    910 |     |            | — |
| PPP loan                      |     |       |  1,376 |     |      |  1,376 |     |            | — |
| Total contractual obligations |     | $     | 48,207 |     | $    | 48,207 |     | $          | — |

Critical Accounting Estimates Management’s discussion and analysis of our financial condition and results of operations is based on our audited consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these audited consolidated financial statements requires us to make estimates and assumptions for the reported amounts of assets, liabilities, revenue, expenses and related disclosures. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions and any such differences may be material. While our significant accounting policies are described in more detail in Note 2 to our audited consolidated financial statements included elsewhere in this proxy statement/prospectus, we believe the following accounting estimates to be critical to the preparation of our audited consolidated financial statements.

272 Government Grants We receive payments from government entities under non -refundablegrants in support of our product development programs. The grants received fall within two categories: a. Expense Reimbursement Grants— grants in which we are entitled to claim from a government entity reimbursement of certain qualified expenses incurred to date. The nature and amount of such expenses are determined by each respective grant; b. Fixed Fee Grants— grants in which the total amount of the